June 2017

NLG919

NLG919 NLG919 is an inhibitor of indoleamine-2,3-dioxygenase (IDO). This compound displays anticancer chemotherapeutic activity, prolonging survival rates in animal models of glioblastoma. References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18949383 Cas No. 1402836-58-1 Purity ≥98%…